Skip to Main Content

Paper Details

Protein-altering germline mutations implicate novel genes related to lung cancer development.
Nat Commun
28
2020
ATM, ATM L2307F allele, KIAA0930, L2307F, Q4X, adenocarcinoma, lung cancer, lung tumors, novel genes, rare variants, rs150665432, rs56009889, uncharacterized gene
Author NameAffiliation
Maria Teresa LandiNational Cancer Institute, National Institutes of Health
Dakai ZhuGeisel School of Medicine at Dartmouth
Dakai ZhuThe Institute for Clinical and Translational Research, Baylor College of Medicine
Xiangjun XiaoThe Institute for Clinical and Translational Research, Baylor College of Medicine
Younghun HanThe Institute for Clinical and Translational Research, Baylor College of Medicine
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto
Yonathan BrhaneLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto
Neil E CaporasoNational Cancer Institute, National Institutes of Health
Neil E CaporasoNational Cancer Institute, National Institutes of Health
Geoffrey LiuLunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto
Loic Le MarchandUniversity of Hawaii Cancer Center
Demetrius AlbanesNational Cancer Institute, National Institutes of Health
Heike Bickeb??llerUniversity Medical Center, Georg-August-University Gottingen
William S BushCase Western Reserve University
Jinyoung ByunThe Institute for Clinical and Translational Research, Baylor College of Medicine
John K FieldInstitute of Translational Medicine, University of Liverpool
Lambertus A KiemeneyRadboud University Medical Center, Radboud Institute for Health Sciences
Christopher A HaimanKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Christopher A HaimanKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Hans Brunnstr??mLund University
Olle MelanderLund University
Laure DossusLund University
Domenico PalliHellenic Health Foundation
H-Erich WichmannResearch Unit of Molecular Epidemiology, Institute of Epidemiology II, German Research Center for Environmental Health
Angela RischUniversity of Salzburg and Cancer Cluster Salzburg
Albert RosenbergerUniversity Medical Center, Georg-August-University Gottingen
Frances A ShepherdPrincess Margaret Cancer Centre
Ming-Sound TsaoPrincess Margaret Cancer Centre
Jolanta LissowskaM. Sklodowska-Curie Institute - Oncology Center
Jolanta LissowskaM. Sklodowska-Curie Institute - Oncology Center
Chaitanya BandlamudiMarie-Josee and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Charles M RudinMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerMarie-Josee and Henry R. KravisCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center
John R McLaughlinUniversity of Toronto
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Christopher I AmosThe Institute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosDan L Duncan Comprehensive Cancer Center
Christopher I AmosThe Institute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosDan L Duncan Comprehensive Cancer Center
  • 1 - 47

Datasets